Journal of Evaluation in Clinical Practice 23 (1):114-120 (2017)
| Abstract | This article has no associated abstract. (fix it) |
| Keywords | No keywords specified (fix it) |
| Categories | (categorize this paper) |
| DOI | 10.1111/jep.12622 |
| Options |
Mark as duplicate
Export citation
Request removal from index
|
Download options
References found in this work BETA
What Evidence in Evidence-Based Medicine?John Worrall - 2002 - Proceedings of the Philosophy of Science Association 2002 (3):S316-S330.
What Evidence in Evidence‐Based Medicine?John Worrall - 2002 - Philosophy of Science 69 (S3):S316-S330.
Evidence Based or Person Centered? An Ontological Debate.Rani Lill Anjum - 2016 - European Journal for Person Centered Healthcare 4 (2):421-429.
Hempelian and Kuhnian Approaches in the Philosophy of Medicine: The Semmelweis Case.Donald Gillies - 2005 - Studies in History and Philosophy of Biological and Biomedical Sciences 36 (1):159-181.
Hempelian and Kuhnian Approaches in the Philosophy of Medicine: The Semmelweis Case.Donald Gillies - 2005 - Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 36 (1):159-181.
View all 6 references / Add more references
Citations of this work BETA
Artificial Intelligence Methods for a Bayesian Epistemology‐Powered Evidence Evaluation.Francesco De Pretis, Jürgen Landes & William Peden - 2021 - Journal of Evaluation in Clinical Practice 27 (3):504-512.
What is the Guidelines Challenge? The CauseHealth Perspective.Rani Lill Anjum - 2018 - Journal of Evaluation in Clinical Practice 24 (5):1127-1131.
The Guidelines Challenge-Philosophy, Practice, Policy.Rani Lill Anjum, Samantha Copeland, Roger Kerry & Elena Rocca - 2018 - Journal of Evaluation in Clinical Practice 24 (5):1120-1126.
Framing the Epistemic Schism of Statistical Mechanics.Javier Anta - 2021 - Proceedings of the X Conference of the Spanish Society of Logic, Methodology and Philosophy of Science.
Similar books and articles
Mechanistic Information as Evidence in Decision-Oriented Science.José Luis Luján, Oliver Todt & Juan Bautista Bengoetxea - 2016 - Journal for General Philosophy of Science / Zeitschrift für Allgemeine Wissenschaftstheorie 47 (2):293-306.
Informal Risk Assessment Strategies in Health Care Staff: An Unrecognized Source of Resilience?Konstantinos Arfanis & Andrew Smith - 2012 - Journal of Evaluation in Clinical Practice 18 (6):1140-1146.
Cambodian Patients' and Health Professionals' Views Regarding the Allocation of Antiretroviral Drugs.Jean‐Phlippe Dousset Stephanie Nann - 2012 - Developing World Bioethics 12 (2):96-103.
Consumer Believability of Information in Direct-to-Consumer (DTC) Advertising of Prescription Drugs.Richard F. Beltramini - 2006 - Journal of Business Ethics 63 (4):333 - 343.
The Painter and the Cameraman: Boundaries in Clinical Relationships.Arthur W. Frank - 2002 - Theoretical Medicine and Bioethics 23 (3):219-232.
Quantitative Analysis of Ethical Issues in Phase I Trials: A Survey Interview of 144 Advanced Cancer Patients.Christopher K. Daugherty, Donald M. Banik, Linda Janish & Mark J. Ratain - 1999 - IRB: Ethics & Human Research 22 (3):6-14.
Optimal Drug Use and Rational Drug Policy.Geoffrey F. Miller - 2011 - Behavioral and Brain Sciences 34 (6):318-319.
Maintaining Therapeutic Boundaries: The Motive is Therapeutic Effectiveness, Not Defensive Practice.Debra S. Borys - 1994 - Ethics and Behavior 4 (3):267 – 273.
Prerequisites for Implementing Cardiovascular Absolute Risk Assessment in General Practice: A Qualitative Study of Australian General Practitioners' and Patients' Views.Qing Wan, Mark F. Harris, Nicholas Zwar, Sanjyot Vagholkar & Terry Campbell - 2010 - Journal of Evaluation in Clinical Practice 16 (3):580-584.
Cambodian Patients' and Health Professionals' Views Regarding the Allocation of Antiretroviral Drugs.Stephanie Nann, Jean-Phlippe Dousset, Chanthy Sok, Pisey Khim, Sopheap Y., Paul Sorum & Etienne Mullet - 2012 - Developing World Bioethics 12 (2):96-103.
Some Public Policy Problems with the Science of Carcinogen Risk Assessment.Carl F. Cranor - 1988 - PSA: Proceedings of the Biennial Meeting of the Philosophy of Science Association 1988:467 - 488.
Negative Mechanistic Reasoning in Medical Intervention Assessment.Jesper Jerkert - 2015 - Theoretical Medicine and Bioethics 36 (6):425-437.
Conceptual Questions and Challenges Associated with the Traditional Risk Assessment Paradigm for Nanomaterials.Jutta Jahnel - 2015 - NanoEthics 9 (3):261-276.
The Placebo Phenomenon and Medical Ethics: Rethinking the Relationship Between Informed Consent and Risk–Benefit Assessment.Franklin G. Miller & Luana Colloca - 2011 - Theoretical Medicine and Bioethics 32 (4):229-243.
Analytics
Added to PP index
2016-08-20
Total views
18 ( #605,161 of 2,498,770 )
Recent downloads (6 months)
1 ( #422,193 of 2,498,770 )
2016-08-20
Total views
18 ( #605,161 of 2,498,770 )
Recent downloads (6 months)
1 ( #422,193 of 2,498,770 )
How can I increase my downloads?
Downloads
